Dr. Cooper previously worked as director of Kidney Transplantation, director of Clinical Research, and director of the Transplant Fellowship Program at the University of Maryland School of Medicine.
Cooper earned his medical degree at Georgetown University School of Medicine and completed his postdoctoral work at Johns Hopkins.
As director of MedStar Georgetown’s Kidney Transplant Program, Dr. Cooper’s focus will be living donation and living donor safety. “Our number one priority is the safety and positive outcomes for our recipients as well as our living donors,” said Cooper.
Dr. Cooper is currently involved in research to minimize injury to organs during the transplant process called ischemia reperfusion injury. This occurs when the blood supply is cut off from donor organ and then reintroduced into the organ by the recipient. “We’re studying ways to give medication to the recipient that would give the kidney a better environment and reduce the severity and the incidence of this injury,” said Dr. Cooper. “These improvements could lead to organs lasting longer in a recipient with lower chances of rejection, particularly in cases where the recipient is receiving a deceased donor organ.”
Dr. Cooper says this could also lead to a greater number of viable donor organs that might otherwise not be suitable for transplant.
He plans to work with physicians, clinical staff and leaders throughout MedStar Health to continue growing this program providing a much needed service to our community, which suffers from a high rate of kidney disease.
Media Contact: Marianne Worley (MGUH)
Patient Contact: 202-342-2400